Evaluation of total HIV-DNA changes in HIV-1 infected patients who continue a 2-drug regimen with dolutegravir plus one reverse transcriptase inhibitor or switch to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide enrolled in the Be-One Study
Abstract
Publication Date:
2019
Iris type:
1.5 Abstract in rivista
List of contributors:
Santoro, M. M.; Gianotti, N.; Galli, L.; Scutari, R.; Alteri, C.; Poli, A.; Piermatteo, L.; Bigoloni, A.; Perno, C. F.; Lazzarin, A.; Ceccherini-Silberstein, F.; Castagna, A.
Published in: